AmeriServ Wealth Advisors’s Celgene Corp CELG Stock Holding History

AmeriServ Wealth Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,126	Closed	-$222K	–	74
2016 Q3	$222K	Buy	+2,126	New	+$230K	0.28%	59
2015 Q4	–	Sell	-3,181	Closed	-$344K	–	60
2015 Q3	$344K	Sell	3,181 -571	-15%	-$70.9K	0.66%	38
2015 Q2	$434K	Buy	3,752 +118	+3%	+$13.5K	0.5%	43
2015 Q1	$419K	Buy	3,634 +90	+3%	+$10.8K	0.48%	45
2014 Q4	$396K	Buy	3,544 +157	+5%	+$16.6K	0.38%	69
2014 Q3	$321K	Buy	3,387 +285	+9%	+$25.7K	0.56%	69
2014 Q2	$266K	Hold	3,102	–	–	0.29%	95
2014 Q1	$217K	Buy	+3,102	New	+$246K	0.22%	122

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AmeriServ Wealth Advisors's CELG Position: Q4 2016 in Review

AmeriServ Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 2,126 shares — an estimated $222K sold.

AmeriServ Wealth Advisors first reported a position in CELG in Q1 2014 and held it in 8 quarters. The position peaked at $434K in Q2 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

AmeriServ Wealth Advisors reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
AmeriServ Wealth Advisors sold 2,126 Celgene Corp shares in Q4 2016, an estimated $222K.
AmeriServ Wealth Advisors first reported a position in Celgene Corp in Q1 2014 and held it in 8 quarters.
AmeriServ Wealth Advisors's Celgene Corp position peaked at $434K in Q2 2015.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on AmeriServ Wealth Advisors's 13F filing for Q4 2016, filed 30 Jan 2017.